ProCE Banner Activity

How I Improve Patient Outcomes With Daratumumab Therapy

Clinical Thought
Carol Ann Huff, MD, discusses the clinical impact of the monoclonal antibody daratumumab for the treatment of patients with multiple myeloma, with practical insights for using this agent in your practice.

Released: March 02, 2018

Expiration: March 01, 2019

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

Celgene

Takeda Oncology